197 related articles for article (PubMed ID: 31204400)
21. The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.
Johnson CS; Louie BE; Wille A; Dunst CM; Worrell SG; DeMeester SR; Reynolds J; Dixon J; Lipham JC; Lada M; Peters JH; Watson TJ; Farivar AS; Aye RW
J Gastrointest Surg; 2015 May; 19(5):799-805. PubMed ID: 25740341
[TBL] [Abstract][Full Text] [Related]
22. Durability of radiofrequency ablation for long-segment and ultralong-segment Barrett's esophagus over 10 years.
Nguyen CL; Tovmassian D; Zhou M; Seyfi D; Gooley S; Falk GL
Surg Endosc; 2024 Mar; 38(3):1239-1248. PubMed ID: 38092973
[TBL] [Abstract][Full Text] [Related]
23. Long-term durability of radiofrequency ablation for Barrett's-related neoplasia.
Haidry R; Lovat L
Curr Opin Gastroenterol; 2015 Jul; 31(4):316-20. PubMed ID: 26039723
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.
Orman ES; Li N; Shaheen NJ
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1245-55. PubMed ID: 23644385
[TBL] [Abstract][Full Text] [Related]
26. Confocal Laser Endomicroscopy vs Biopsies in the Assessment of Persistent or Recurrent Intestinal Metaplasia/Neoplasia after Endoscopic Treatment of Barrett's Esophagus related Neoplasia.
Krajciova J; Kollar M; Maluskova J; Janicko M; Vackova Z; Spicak J; Martinek J
J Gastrointestin Liver Dis; 2020 Sep; 29(3):305-312. PubMed ID: 32919414
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period.
van Munster S; Nieuwenhuis E; Weusten BLAM; Alvarez Herrero L; Bogte A; Alkhalaf A; Schenk BE; Schoon EJ; Curvers W; Koch AD; van de Ven SEM; de Jonge PJF; Tang TJ; Nagengast WB; Peters FTM; Westerhof J; Houben MHMG; Bergman JJ; Pouw RE;
Gut; 2022 Feb; 71(2):265-276. PubMed ID: 33753417
[TBL] [Abstract][Full Text] [Related]
28. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
29. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry.
Wolfson P; Ho KMA; Wilson A; McBain H; Hogan A; Lipman G; Dunn J; Haidry R; Novelli M; Olivo A; Lovat LB;
Gastrointest Endosc; 2022 Aug; 96(2):223-233. PubMed ID: 35189088
[TBL] [Abstract][Full Text] [Related]
31. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
Dunbar KB
Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
[TBL] [Abstract][Full Text] [Related]
33. Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett's esophagus following complete eradication of dysplasia: a single-center retrospective cohort study.
Kobayashi R; Calo NC; Marcon N; Iwaya Y; Shimamura Y; Honda H; Streutker C; Mosko J; May G; Teshima C
Surg Endosc; 2022 Jul; 36(7):5041-5048. PubMed ID: 34750708
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L
Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation for Barrett's esophagus-related neoplasia.
Krajciova J; Vackova Z; Spicak J; Martinek J
Minerva Chir; 2018 Aug; 73(4):366-377. PubMed ID: 29806757
[TBL] [Abstract][Full Text] [Related]
36. Single-session endoscopic resection and focal radiofrequency ablation for short-segment Barrett's esophagus with early neoplasia.
Barret M; Belghazi K; Weusten BL; Bergman JJ; Pouw RE
Gastrointest Endosc; 2016 Jul; 84(1):29-36. PubMed ID: 26769410
[TBL] [Abstract][Full Text] [Related]
37. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic management of Barrett's dysplasia and early neoplasia: efficacy, safety and long-term outcomes in a UK tertiary centre.
White JR; Ortiz-Fernández-Sordo J; Santiago-García J; Reddiar D; Learoyd A; De Caestecker J; Cole A; Kaye P; Ragunath K
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e413-e422. PubMed ID: 33731587
[TBL] [Abstract][Full Text] [Related]
39. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; ten Kate FJ; Visser M; Seldenrijk CA; van Berge Henegouwen MI; Weusten BL; Bergman JJ
Endoscopy; 2011 Apr; 43(4):282-90. PubMed ID: 21455869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
